Table 2. Changes in glycated hemoglobin and during each study part.

Visit	Sequence 1 (pitavastatin to atorvastatin)		Visit	Sequence 2 (atorvastatin to pitavastatin)
	Mean ± SD	Mean change ± SD		Mean ± SD	Mean change ± SD
	n = 14	n = 14		n = 14	n = 14
Visit 1 (baseline)	6.79 ± 0.38	–	Visit 1 (baseline)	6.78 ± 0.76	–
Visit 2 (pitavastatin)	6.66 ± 0.51	−0.13 ± 0.26	Visit 2 (atorvastatin)	7.01 ± 1.23	0.23 ± 0.61
Visit 3 (atorvastatin)	6.84 ± 0.59	0.04 ± 0.29	Visit 3 (pitavastatin)	6.81 ± 0.98	0.04 ± 0.55
HbA1c after treatment		Difference between two statin treatments (95% CI)		P‐value for statin effect	P‐value for sequence effect
Pitavastatin	Atorvastatin
6.74	6.92	−0.18 (−0.34, −0.02)		0.03	0.26

CI, confidence interval. SD, standard deviation.